LCP1 is overexpressed in olaparib-resistant ovarian cancer cells, and downregulation of LCP1 can increase olaparib-induced apoptotic cell death and the sensitivity of ovarian cancer to olaparib. Here, LCP1 is linked to ovarian carcinoma.